Has COVID-19 suppressed dengue transmission in Nepal?. (18th November 2022)

• Record Type: Journal Article
• Authors: Pandey, Basu Dev; Ngwe Tun, Mya Myat; Pandey, Kishor; Dumre, Shyam Prakash; Bhandari, Pramananda; Pyakurel, Uttam Raj; Pokhrel, Nayanum; Dhimal, Meghanath; Gyanwali, Pardip; Culleton, Richard; Takamatsu, Yuki; Costello, Anthony; Morita, Kouichi
• Is Part Of: Epidemiology and infection. Volume 150(2022)
• Publication Date: 2022-11-18
• Subjects: COVID-19 -- Dengue -- Nepal; Communicable diseases -- Periodicals; Epidemiology -- Periodicals; 614.4
• DOI: 10.1017/S0950268822001790
• Languages: English
• ISSNs: 0950-2688

Abstract

Abstract: Following the report of the first COVID-19 case in Nepal on 23 January 2020, three major waves were documented between 2020 and 2021. By the end of July 2022, 986 596 cases of confirmed COVID-19 and 11 967 deaths had been reported and 70.5% of the population had received at least two doses of a COVID-19 vaccine. Prior to the pandemic, a large dengue virus (DENV) epidemic affected 68 out of 77 districts, with 17 932 cases and six deaths recorded in 2019. In contrast, the country's Epidemiology and Disease Control Division reported 530 and 540 dengue cases in the pandemic period (2020 and 2021), respectively. Furthermore, Kathmandu reported just 63 dengue cases during 2020 and 2021, significantly lower than the 1463 cases reported in 2019. Serological assay showed 3.2% positivity rates for anti-dengue immunoglobulin M antibodies during the pandemic period, contrasting with 26.9–40% prior to it. Real-time polymerase chain reaction for DENV showed a 0.5% positive rate during the COVID-19 pandemic which is far lower than the 57.0% recorded in 2019. Continuing analyses of dengue incidence and further strengthening of surveillance and collaboration at the regional and international levels are required to fully understand whether the reduction in dengue incidence/transmission were caused by movement restrictions during the COVID-19 pandemic.